Around 1.9 million Australians were regularly dispensed five or more medicines at the same time in 2025, according to the first report on polypharmacy ever published by the Australian Institute of Health and Welfare (AIHW).
A new synthetic opioid, cychlorphine, is spreading through illicit drug markets in Europe and North America.
Several regulatory, funding and accreditation changes will land on 1 October 2026. AP breaks down what pharmacists need to know.
COVID-19 vaccines will move onto the National Immunisation Program later this week. Who is now eligible for a funded vaccine and what should pharmacists tell patients who aren’t?
The TGA has removed Andrographis from the listed medicines framework. Here’s what pharmacists need to know about affected products, product recalls and patient counselling.
As ADHD medicine use surges and prescribing pathways evolve, pharmacists are increasingly acting as a clinical safety net and health system navigator.
Pharmacists across Australia can access thousands in government funding to complete PSA’s Graduate Certificate in Pharmacist Prescribing.
Demand for unapproved peptide products has moved from the black market to compounding pharmacies. Here's what pharmacists need to know.
From 1 October 2026, COVID-19 vaccination will move from its pandemic-era funding model onto the NIPVIP program.
New advice from the Therapeutic Guidelines highlights that tirzepatide could interfere with the efficacy of oral contraceptives.
